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To the Editor:
Noncommunicable  diseases  (NCDs)  are  a  global  chal-
lenge. During the next several decades, NCDs will govern 
the  health  care  needs  of  populations  in  most  low-  and 
middle-income  countries  because  of  declines  in  com-
municable diseases, conditions related to childbirth and 
nutrition, changes in lifestyle factors (eg, smoking), and 
population aging (1). We examined the burden of NCDs 
in the Hashemite Kingdom of Jordan. We computed the 
projected prevalence of diabetes, hypertension, and high 
blood cholesterol. All of these risk factors are associated 
with  an  increased  risk  of  cardiovascular  disease  (CVD) 
— the leading cause of death in Jordan — and increased 
health care use.
In  2005,  Jordan’s  population  was  approximately  5.5 
million. By 2050, the population is expected to increase 
to between 8.5 and 14.8 million people. (2) The proportion 
of older people (aged 60 years or older) is expected to be 
15.6% (or approximately 1.8 million people) in 2050, more 
than 3 times that in 2000 (2).
During 2005, NCDs accounted for more than 50% of all 
deaths in Jordan. Heart disease and stroke (International 
Statistical Classification of Diseases, 10th Revision, codes 
I00-I99) accounted for 35% of all deaths; malignant neo-
plasms (C00-C97) were responsible for 13% of deaths (3). 
Nearly 60% of deaths from malignant neoplasms occurred 
among people younger than 65 years, and approximately 
one-third of those who died from CVD were aged 65 or 
younger.
During  2004,  approximately  400,000  (15%)  Jordanian 
adults had diabetes (an increase from 7% in 1996), and 
an estimated 350,000 (12%) had impaired fasting glucose 
(4,5). Approximately 15% of adults reported hypertension, 
and roughly 23% had high blood cholesterol — an increase 
from 9% in 1996 (4,5).
We computed crude estimates of the growing prevalence 
of NCD risk factors using Jordan’s projected population 
estimates from 2005 through 2050 (2). We analyzed hyper-
tension, high blood cholesterol, and diabetes prevalence 
estimates collected from a household survey in 2004 (4,5). 
For each risk factor, population projections were multi-
plied  by  the  risk  factor  prevalence  estimates  (based  on 
self-reported  physician-diagnosed  disease)  to  obtain  the 
projected population with diabetes, hypertension, or high 
blood cholesterol for each time period.
The projected population in Jordan from 2005 to 2050 
with diabetes, hypertension, or high blood cholesterol is 
shown in Figures 1 through 3. Four possible scenarios are 
displayed in each graphic. The first scenario applies the 
2004 estimated risk factor prevalence and assumes that 
this prevalence remains constant.  Each of the remaining 
scenarios starts with the 2004 estimated prevalence and 
applies a 0.1, 0.25, or 0.5 percentage point annual increase 
to the projected population estimates. These increments 
are  somewhat  arbitrary  because  they  are  not  based  on 
past  experience  in  Jordan  but  reflect  possible  annual 
increases in prevalence.
The projected population in Jordan with each risk factor 
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during 2050 ranged from 0.76 to 3.04 million people for 
diabetes, from 1.50 to 3.78 million for hypertension, and 
from 0.65 to 2.93 million for high blood cholesterol depend-
ing on the 4 possible scenarios noted above. For example, 
assuming  the  prevalence  of  diabetes  observed  in  2004 
remained at 7.5% through 2050, approximately 750,000 
people in Jordan would be expected to have diabetes in 
2050 (all other things being equal) (Figure 1). If the preva-
lence of diabetes increased at 0.5 percentage points per 
year during the period, approximately 3 million people, 
or 30% of the Jordanian population, would be expected to 
have diabetes in 2050 (all other things being equal).
Our crude estimates suggest that approximately 1 to 3 
million people in Jordan will have diabetes, hypertension, 
or high blood cholesterol by 2050 depending on changes 
in disease prevalence and the growth of the population. 
There are at least 4 limitations to our study: the initial 
prevalence  is  based  on  self-reported  disease  status  and 
therefore may underestimate the true prevalence; many 
people will have multiple risk factors that increase their 
risk for heart disease and stroke; the annual increments in 
prevalence were arbitrarily chosen and not based on past 
experience in Jordan; and we did not take into account dif-
ferences in age-specific risk factor prevalence over time.
Similar risk factor patterns exist across the region. The 
proportion of all deaths attributable to NCDs in the World 
Health  Organization’s  Eastern  Mediterranean  Region  is 
projected  to  increase  from  51%  during  2005  to  66%  by   
2030  (6).   Assuming  prevalences  are  similar  to  that  in 
Jordan,  diabetes  may  affect  nearly  10  million  people  in 
Egypt, one of the region’s largest countries, and 3 million 
people in Saudi Arabia. Hypertension may affect 18 million 
Egyptians and 6.5 million people in Saudi Arabia by 2050.
Programs to monitor and control risk factors, clinical ser-
vices, and a robust health care system will be important to 
successfully improve NCD outcomes and reduce the burden 
of disease. Reducing the prevalence of NCDs will require 
a renewed commitment by governmental and nongovern-
Figure 1. Projected population with diabetes mellitus in Jordan from 
2005 to 2050 according to 4 different projected prevalence variants. 
Figure generated by the authors using data from the Population Division 
of the Department of Economic and Social Affairs of the United Nations 
Secretariat (2) and Zindah et al (5). 
Figure 2. Projected population with hypertension in Jordan from 2005 
to 2050 according to 4 different projected prevalence variants. Figure 
generated by the authors using data from the Population Division of 
the Department of Economic and Social Affairs of the United Nations 
Secretariat (2) and Zindah et al (5). 
Figure 3. Projected population with high blood cholesterol in Jordan from 
2005 to 2050 according to 4 different projected prevalence variants. 
Figure generated by the authors using data from the Population Division 
of the Department of Economic and Social Affairs of the United Nations 
Secretariat (2) and Zindah et al (5). VOLUME 6: NO. 2
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mental  institutions,  by  public  health  professionals  and 
clinical practitioners, and by communities and individu-
als to acknowledge the burden of NCDs and the need for 
timely action. Moreover, stimulating, strengthening, and 
sustaining regional efforts and programs are necessary to 
reduce the prevalence of NCDs through coordinated and 
integrated programs of health promotion and disease pre-
vention. These programs should involve networks for risk 
factor surveillance, information sharing, capacity building, 
advocacy, policy development, and collaboration in gener-
ating, disseminating, and applying knowledge.
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